Quick Takeaways
- BJDX - Bluejay Diagnostics, Inc. has 10 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 10 Insiders of Bluejay Diagnostics, Inc.
- Symbol
- BJDX on Nasdaq
- Location
- Acton, MA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 16 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Bluejay Diagnostics, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Douglas Clark Wurth | Director | $7,103,516 | Mixed | 01 Feb 2023 | ||
| Donald R. Chase | Director | $2,434,056 | Mixed | 01 Feb 2023 | ||
| Indranil Dey | President and CEO, Director, 10%+ Owner | $715,596 | Mixed | 13 Dec 2023 | ||
| Svetlana Dey | Director | $632,626 | Mixed | 13 Dec 2023 | ||
| Kenneth R. Fisher | Chief Financial Officer | $347,475 | Mixed | 01 Feb 2023 | ||
| Jason Cook | Chief Technology Officer | $137,843 | Mixed | 07 Mar 2023 | ||
| Fred S. Zeidman | Director | $84,425 | Mixed | 01 Feb 2023 | ||
| Gary G. Gemignani | Director | $84,425 | Mixed | 01 Feb 2023 | ||
| Gordon Winston Kinder | Chief Financial Officer | $56,795 | Mixed | 17 Mar 2022 | ||
| Frances P. Scally | Cfo | Mixed | 26 Sep 2023 |
Top shareholders of Bluejay Diagnostics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Douglas Clark Wurth |
3/4/5
|
Director |
—
class O/S missing
|
2,313,849
|
$7,103,516 | — | 01 Feb 2023 | |
| Donald R. Chase |
3/4/5
|
Director |
—
class O/S missing
|
792,852
|
$2,434,056 | — | 01 Feb 2023 | |
| Indranil Dey |
3/4/5
|
President and CEO, Director, 10%+ Owner |
—
class O/S missing
|
233,093
|
$715,596 | — | 13 Dec 2023 | |
| Svetlana Dey |
3/4/5
|
Director |
—
class O/S missing
|
206,067
|
$632,626 | — | 13 Dec 2023 | |
| Kenneth R. Fisher |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
113,184
|
$347,475 | — | 01 Feb 2023 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
10%
|
194,132
|
$147,540 | $0 | 31 Dec 2025 | |
| Jason Cook |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
44,900
|
$137,843 | — | 07 Mar 2023 | |
| Braeden Lichti |
13D/G
|
— |
3.6%
|
35,500
|
$115,375 | $0 | 11 Mar 2026 | |
| NORTHSTRIVE FUND II LP |
13D/G
|
Braeden Lichti |
3.6%
|
35,500
|
$115,375 | $0 | 11 Mar 2026 | |
| Fred S. Zeidman |
3/4/5
|
Director |
—
class O/S missing
|
27,500
|
$84,425 | — | 01 Feb 2023 | |
| Gary G. Gemignani |
3/4/5
|
Director |
—
class O/S missing
|
27,500
|
$84,425 | — | 01 Feb 2023 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
91,537
|
$59,499 | -$55,928 | 31 Dec 2025 | |
| Gordon Winston Kinder |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
18,500
|
$56,795 | — | 17 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.2%
|
41,794
|
$27,885 | — | 31 Dec 2025 | |
| Anson Funds Management LP |
13D/G
|
— |
1.4%
|
367,950
|
$25,756 | $0 | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.7%
|
32,100
|
$21,417 | — | 31 Dec 2025 | |
| L1 Capital Global Opportunities Master Fund, Ltd. |
13D/G
|
— |
0.82%
|
221,251
|
$15,488 | $0 | 31 Dec 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.74%
|
14,351
|
$9,575 | — | 31 Dec 2025 | |
| SABBY MANAGEMENT, LLC |
13D/G
|
— |
4.9%
|
27,587
|
$7,173 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
10,256
|
$6,842 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.23%
|
4,433
|
$2,958 | — | 31 Dec 2025 | |
| L1 Global Manager Pty Ltd |
13F
|
Company |
0.02%
|
483
|
$226 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
15
|
$10 | — | 31 Dec 2025 | |
| METEORA CAPITAL, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Bluejay Diagnostics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.